In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Novartis and Emisphere agree to execute oral calcitonin license agreement
Emisphere and Elan restructure relationship
Emisphere Technologies Inc. Signs Licensing Agreement with Roche to Develop Oral Formulations
Novartis extends collaboration with Emisphere
DuPont and Emisphere announce oral heparin agreement
Emisphere initiates R and D agreement with U.S. Army
Emisphere Technologies establishes obesity collaboration with Regeneron